Apple is presently grappling with a patent controversy concerning several smartwatch versions they've introduced recently. It is somewhat bewildering that the firm has chosen to pre-emptively withdraw select Apple Watches from their inventory. This maneuver comes prior to a foreseen ban on these items.

The initial announcement hinting towards these Apple Watches being banned stated they would persist in selling leading up to the holiday season. Therefore, it comes as a surprise that the Apple Watch Series 9 and Apple Watch Ultra 2 have already disappeared from online accessibility. The import ban is set to kick in from 6th December while the physical stores will follow suit and stop sales by December 24th.

Those who are keen on procuring one of the more recent models will have to resort to other online platforms due to this development. This decision by Apple could be a reaction to the latest turn of events in the ongoing patent disagreement, which resulted in the International Trade Commission denying Apple's bid to defer the ban.

Apple is, nevertheless, striving to engineer a way around the main issue, which is the claim of patent infringement. Apple has reached out to the Biden administration, with the hope they will overturn this ruling. The final judgment is yet to be made public, which is anticipated next week.

If the appeal falls through, Apple has another contingency plan. The manufacturers are developing a software update which, once approved by the ITC, could result in the disputed Apple Watches returning to the market. However, their potential solutions are not guaranteed to be successful as they rely on approval from various entities.

If both paths fail to succeed, Apple will be necessitated to keep these watches off the market until a licensing agreement can be reached. Another alternative is for Apple to design a completely new SpO2 sensor to facilitate the selling of these devices. For now, a verdict by the Biden administration along with ITC's nod for their software update submission is eagerly awaited by Apple.

The patent infringement allegation against Apple involves using patented technology from the medical company, Masimo, specifically its pulse oximeter functions. Apple has been striving to rectify this issue ever since the ruling by the ITC, roughly two months ago. Masimo claims that Apple illegally acquired some of its top ranking executives and employees just before launching its new pulse rate function. Apple's retort to Masimo's proposal for a licensing deal was an effort to overturn the verdict. Apple insists that they are looking into all possible legal and technical routes to ensure that their smartwatches remain available to their customers.